Maternally Transferred Thyroid Disease in the Infant: Recognition and Treatment

  • Thomas P. FoleyJr.
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 299)


Throughout pregnancy the fetus is dependent upon the placental transport of nutrients from the mother to support growth and differentiation. By this same mechanism the fetus is exposed to a variety of maternal factors that may adversely affect thyroid embryogenesis and function during pregnancy and postnatal life. The maternal factors include altered concentrations of iodide, immunoglobulins primarily in the G class (IgG), drugs, environmental goitrogens and other substances that are poorly understood or defined.


Grave Disease Congenital Hypothyroidism Antithyroid Drug Endemic Goiter Antibody Dependent Cell Mediate Cytotoxicity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    B. S. Hetzel, “The prevention and control of iodine deficiency disorders,” Elsevier, Amsterdam (1987).Google Scholar
  2. 2.
    F. M. Delange, Endemic cretinism, in: “Werner’s The Thyroid,” 5th ed., S. H. Ingbar and L. E. Braverman, eds., J. B. Lippincott Co., Philadelphia (1986).Google Scholar
  3. 3.
    D. A. Fisher, M. R. Pandian, and E. Carlton, Autoimmune thyroid disease: an expanding spectrum. Pediatr Clin North Am 34: 907 (1987).PubMedGoogle Scholar
  4. 4.
    D. A. Fisher, Neonatal thyroid disease in the offspring of women with autoimmune thyroid disease. Thyroid Today 9 (4): 1 (1986).Google Scholar
  5. 5.
    T. Theodoropoulos, L. E. Braverman, and A. G. Vagenakis, Iodide-induced hypothyroidism: a potential hazard during perinatal life. Science 205: 502 (1979).PubMedCrossRefGoogle Scholar
  6. 6.
    A. Grüters, D. L’Allemand, P. H. Heidemann, P.Schürnbrand, Incidence of iodine contamination in neonatal transient hyperthyrotropinemia. Eur J Pediatr 140: 299 (1983).PubMedCrossRefGoogle Scholar
  7. 7.
    R. G. Cheron, M. M. Kaplan, P. R. Larsen, H. A. Selenkow, and J. F. Crigler Jr., Neonatal thyroid function after propylthiouracil therapy for maternal Graves’ disease. N Eng J Med, 304: 525 (1981).CrossRefGoogle Scholar
  8. 8.
    T. P. Foley Jr., Etiology and pathogenesis of congenital hypothyroidism. Endokrynol Polska 41: 343 (1990).Google Scholar
  9. 9.
    A. M. Ermans, Endemic goiter, in: “Werner’s The Thyroid,” S. H. Ingbar and L. E. Braverman, eds., J. B. Lippincott Co., Philadelphia (1986).Google Scholar
  10. 10.
    D. l’Allemand, A. Grüters, P. Beyer, and B. Weber, Iodine in contrast agents and skin disinfectants is the major cause for hypothyroidism in premature infants during intensive care. Horm Res 28: 42 (1987).PubMedCrossRefGoogle Scholar
  11. 11.
    J. P. Chanoine, M. Boulvain, P. Bourdoux, A. Pardou, H. V. Van Thi, A. M. Ermans, and F. Delange, Increased recall rate at screening for congenital hypothyroidism in breast fed infants born to iodine overload mothers. Arch Dis Childh 63: 1207 (1988).PubMedCrossRefGoogle Scholar
  12. 12.
    J. M. McKenzie, Neonatal Graves’ disease. J Clin Endocrinol Metab 24: 660 (1964).PubMedCrossRefGoogle Scholar
  13. 13.
    B. Rees Smith, S. M. McLachlan, and J. Furmaniak, Autoantibodies to the thyrotropin receptor. Endocr Rev 9: 106–21 (1988).PubMedCrossRefGoogle Scholar
  14. 14.
    A. P. Weetman, M. E. Yateman, P. A. Ealey, C. M. Black, C. B. Reimer, R. C. Williams, B. Shine, and N. J. Marshall, Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J Clin Invest 86: 723 (1990).PubMedCrossRefGoogle Scholar
  15. 15.
    R. Bernales and J. A. Bellanti, Fetal and Neonatal Immunology, in: “Fetal and Maternal Medicine,” E. J. Quilligan and N. Kretchmer, eds., John Wiley and Sons, New York (1980).Google Scholar
  16. 16.
    K. Southgate, F. M. Creagh, M. Teece, C. Kingwood, and B. Rees-Smith, A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol (Oxf) 20: 539 (1984).CrossRefGoogle Scholar
  17. 17.
    T. P. Foley Jr, C. White, and A. New, Juvenile Graves’ disease: Usefulness and limitations of thyrotropin receptor antibody determinations. J Pediatr 110: 378 (1987).PubMedCrossRefGoogle Scholar
  18. 18.
    D. A. Fisher and A. H. Klein, Thyroid development and disorders of thyroid function in the newborn. N Eng J Med 304: 702 (1981).CrossRefGoogle Scholar
  19. 19.
    J. S. Dallas and T. P. Foley, Hyperthyroidism, in: “Pediatric Endocrinology: A Clinical Guide,” F. Lifshitz, ed., Marcel Dekker, New York (1990).Google Scholar
  20. 20.
    W. H. Hoffman, P. Sahasrananan, S. S. Ferandos, C. L. Burek, and N. R. Rose, Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS) and LATS-protector-negative, thyroid-stimulating antibody-positive patient with Hashimoto’s thyroiditis. J Clin Endocrinol Metab 56: 354 (1982).CrossRefGoogle Scholar
  21. 21.
    M. Zakarija, J. M. McKenzie, and D. S. Munro, Immunoglobulin G Inhibitor of Thyroid-stimulating Antibody is a Cause of Delay in the Onset of Neonatal Graves’ Disease. J Clin Invest 72: 1352 (1983).PubMedCrossRefGoogle Scholar
  22. 22.
    M. Zakarija, A. Garcia, and J. M. McKenzie, Studies on multiple thyroid cell membrane-directed antibodies in Graves’s disease. J Clin Invest 76: 1885 (1985).PubMedCrossRefGoogle Scholar
  23. 23.
    H. Tamaki, N. Amino, K. Takeoka, Y. Iwatani, J. Tachi, M. Kimura, N. Mitsuda, K. Mild, O. Nose, O. Tanizawa, and K. Miyai, Prediction of later development of thyrotoxicosis or central hypothyroidism from the cord serum thyroid-stimulating hormone level in neonates born to mothers with Graves disease. J Pediatr 115: 318 (1989).PubMedCrossRefGoogle Scholar
  24. 24.
    T. P. Foley Jr, Thyroid Disease, in: “Current Pediatric Therapy,” S.S. Gellis and B. M. Kagan, eds., W. B. Saunders Co., Phila., 12th Edition (1985).Google Scholar
  25. 25.
    R. M. Blizzard, R. W. Chandler, B. H. Landing, M. D. Pettit, and C. D. West, Maternal autoimmunization to thyroid as probable cause of athyrotic cretinism. N Eng J Med 263: 327 (1960).CrossRefGoogle Scholar
  26. 26.
    J. M. Sutherland, V. M. Esselborn, R. L. Burket, T. B. Skillman, and J. T. Benson, Familial nongoitrous cretinism apparently due to maternal antithyroid antibody. N Eng J Med 263: 336 (1960).CrossRefGoogle Scholar
  27. 27.
    R. E. Goldsmith, A. J. McAdams, P. R. Larsen, M. MacKenzie, and E. V. Hess. Familial autoimmune thyroiditis: Maternal fetal relationship and the role of generalized autoimmunity. J Clin Endocrinol Metab 37: 265 (1973).PubMedCrossRefGoogle Scholar
  28. 28.
    N. Matsuura, Y. Yamanda, Y. Nohara, J. Konishi, K. Kasagi, K. Endo, H. Kojima, and K. Wattaya, Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins. New Eng J Med 303: 738 (1980).PubMedCrossRefGoogle Scholar
  29. 29.
    M. Zakarija, J. M. McKenzie, and M. S. Eidson, Transient neonatal hypothyroidism: characterization of maternal antibodies to the thyrotropin receptor. J Clin Endocrinol Metab 70: 1239 (1990).PubMedCrossRefGoogle Scholar
  30. 30.
    U. Bogner, A. Grüters, B. Sigle, H. Helge, and H. Schleusener, Cytotoxic antibodies in congenital hypothyroidism. J Clin Endocrinol Metab 68: 671 (1989).PubMedCrossRefGoogle Scholar
  31. 31.
    R. D. Van der Gaag, H. A. Drexhage, and J. H. Dussault, Role of maternal immunoglobulins blocking TSH-induced thyroid growth in sporadic forms of congenital hypothyroidism. Lancet 1: 246 (1985).PubMedCrossRefGoogle Scholar
  32. 32.
    P. van Trotsenburg, T. Vulsma, A. M. Bloot, R. D. Van der Gaag, J. W. Lens, H. A. Drexhage, and J. J. de Vijlder, Antibodies to ‘second colloid antigen’. A study on the prevalence in sporadic forms of congenital hypothyroidism. Acta Endocrinol 121: 659 (1989).PubMedGoogle Scholar
  33. 33.
    Germak JA, Foley, TP Jr. Longitudinal assessment of L-thyroxine therapy for congenital hypothyroidism. J Pediatr 1990, 117: 211–219.PubMedCrossRefGoogle Scholar
  34. 34.
    J. F. Rovet, Congenital hypothyroidism: Intellectual and neuropsychological functioning, in: “Psychoneuroendocrinology: Brain, Behavior, and Hormonal Interactions,” C. S. Holmes, ed., Springer-Verlag Publishers, New York (1990).Google Scholar
  35. 35.
    Roti, E., Gnudi, A., Braverman, L.E.: The placental transport, synthesis and metabolism of hormones and drugs which affect thyroid function. Endocr Rev 4: 131 (1983).PubMedCrossRefGoogle Scholar
  36. 36.
    D. R. Hollingsworth, Hyperthyroidism in pregnancy, in: “Werner’s The Thyroid,” S. H. Ingbar and L. E. Braverman, eds., J. B. Lippincott Co., Philadelphia (1986).Google Scholar
  37. 37.
    W. D. Fisher, M. L. Voorhess, and L. I. Gardner, Congenital hypothyroidism in infant following maternal I1s’ therapy, J Pediatr 62: 132 (1963).PubMedCrossRefGoogle Scholar
  38. 38.
    A. J. Van Herle, R. T. Young, D. A. Fisher, R. P. Uller, and C. R. Brinkman, III, Intra-uterine treatment of a hypothyroid fetus. J Clin Endocrinol Metab 40: 474 (1975).PubMedCrossRefGoogle Scholar
  39. 39.
    E. S. Lightner, D. A. Fisher, H. Giles, and J. Woolfenden, Intra-amniotic injection of thyroxine (T4) to a human fetus. Am J Obstet Gynecol 127: 487 (1977).PubMedGoogle Scholar
  40. 40.
    Dumont JE, Vassart G, Refetoff S. Thyroid disorders. In: The Metabolic Basis of Inherited Disease, Scriver CR, Beaudet AL, Sly WS, Valle D. (eds.) McGraw-Hill, New York, 1989, Chapter 73, pp. 1843–79.Google Scholar
  41. 41.
    Foley TP Jr: “Familial Thyroid Dyshormonogenesis”, In: Pediatric Thyroidology, Delange F, Fisher DA, Malvaux P, Eds., S. Karger AG Medical and Scientific Publishers, Basal, Switzerland, 1985, 17488.Google Scholar
  42. 42.
    D. A. Fisher, J. H. Dussault, T. P. Foley, Jr., A. H. Klein, S. I. Franchi, P. R. Larsen, M. L. Mitchell, W. H. Murphey, and P.G. Walfish, Screening for congenital hypothyroidism: Results of screening 1 million North American infants. J Pediatr, 94: 700 (1979).PubMedCrossRefGoogle Scholar
  43. 43.
    T. P. Foley, Jr., J. Zeng, and T. Torresani, Congenital transient thyroid dyshormonogenesis: A post TSH receptor disorder, (in preparation).Google Scholar
  44. 44.
    J. S. Dallas, T. P. Foley, Jr, and T. Torresani, The presence of thyrotropin-binding immunoglobulin G in sera from children and its effects on in vitro rat thyroid cell function. (submitted)Google Scholar
  45. 45.
    D. Deme, A. Virion, N. A. Hammou, and J. Pommier, NADPHdependent generation of H2O2 in a thyroid particulate fraction requires Ca“. FEBS Lett, 186: 107 (1985).PubMedCrossRefGoogle Scholar
  46. 46.
    K. Miki, O. Nose, K. Miyai, H. Yabuuchi, and T. Harada, Transient infantile hyperthyrotropinaemia, Arch Dis Childh 64: 1177, (1989).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Thomas P. FoleyJr.
    • 1
  1. 1.Department of PediatricsUniversity of PittsburghPittsburghUSA

Personalised recommendations